Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND3 pseudogene 10 (MTND3P10) is classified as a pseudogene, i.e., a genome segment that resembles a protein-coding gene (in this case, the mitochondrial gene MT-ND3) but is non-functional and does not result in an expressed, functional protein[2][4][7]. It is not a therapeutic target, nor does it encode an enzyme, receptor, or other druggable protein class. There are no known biological activities, therapeutic uses, or disease associations directly linked to the MTND3P10 pseudogene. Most references to disease or function relate instead to the active MT-ND3 gene and its protein product, not to this pseudogene[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND3 pseudogene 10 (MTND3P10).